These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 34206708)

  • 21. New and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): Focus on cardiovascular and neurological diseases.
    Mascolo A; Sessa M; Scavone C; De Angelis A; Vitale C; Berrino L; Rossi F; Rosano G; Capuano A
    Int J Cardiol; 2017 Jan; 227():734-742. PubMed ID: 27823897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renin-angiotensin system in atherosclerosis].
    Fukuda D; Sata M
    Nihon Rinsho; 2006 Apr; 64(4):805-9. PubMed ID: 16613201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.
    Manrique C; Lastra G; Gardner M; Sowers JR
    Med Clin North Am; 2009 May; 93(3):569-82. PubMed ID: 19427492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
    Jacoby DS; Rader DJ
    Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.
    Hillaert MA; Lentjes EG; Beygui F; Kemperman H; Asselbergs FW; Nathoe HM; Agostoni P; Voskuil M; Ivanes F; Jude B; Bertrand ME; Pasterkamp G; van der Graaf Y; Doevendans PA; Montalescot G; Van Belle E
    Am Heart J; 2011 Oct; 162(4):585-96. PubMed ID: 21982648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation].
    Giestas A; Palma I; Ramos MH
    Acta Med Port; 2010; 23(4):677-88. PubMed ID: 20687997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic and clinical aspects of renin-angiotensin-aldosterone system blockade in the prevention of diabetes mellitus and cardiovascular disease.
    Hershon KS
    Endocr Pract; 2011; 17(3):430-40. PubMed ID: 21454245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin-angiotensin system and cardiovascular risk.
    Schmieder RE; Hilgers KF; Schlaich MP; Schmidt BM
    Lancet; 2007 Apr; 369(9568):1208-19. PubMed ID: 17416265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes.
    Tikellis C; Pickering RJ; Tsorotes D; Harjutsalo V; Thorn L; Ahola A; Wadén J; Tolonen N; Saraheimo M; Gordin D; Forsblom C; Groop PH; Cooper ME; Moran J; Thomas MC
    Clin Sci (Lond); 2013 May; 124(10):617-26. PubMed ID: 23216128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel RAAS agonists and antagonists: clinical applications and controversies.
    Romero CA; Orias M; Weir MR
    Nat Rev Endocrinol; 2015 Apr; 11(4):242-52. PubMed ID: 25666495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
    Qian C; Schoemaker RG; van Gilst WH; Roks AJ
    Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RAAS in diabetic retinopathy: mechanisms and therapies.
    Li X; Fu YH; Tong XW; Zhang YT; Shan YY; Xu YX; Pu SD; Gao XY
    Arch Endocrinol Metab; 2024 Apr; 68():e230292. PubMed ID: 38652701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the renin-angiotensin-aldosterone system in bone metabolism.
    Mo C; Ke J; Zhao D; Zhang B
    J Bone Miner Metab; 2020 Nov; 38(6):772-779. PubMed ID: 32734523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin Angiotensin Aldosterone System (RAAS): its biology and drug targets for treating diabetic nephropathy.
    Zain M; Awan FR
    Pak J Pharm Sci; 2014 Sep; 27(5):1379-91. PubMed ID: 25176370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of angiotensin receptor blockers in reducing the risk of cardiovascular disease.
    Abramov D; Carson PE
    J Renin Angiotensin Aldosterone Syst; 2012 Sep; 13(3):317-27. PubMed ID: 22610916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Renin-Angiotensin-Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging.
    Neves MF; Cunha AR; Cunha MR; Gismondi RA; Oigman W
    High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):137-145. PubMed ID: 29476451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.
    McGuire DK; Winterfield JR; Rytlewski JA; Ferrannini E
    Diab Vasc Dis Res; 2008 Mar; 5(1):59-66. PubMed ID: 18398815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias.
    Iravanian S; Dudley SC
    Heart Rhythm; 2008 Jun; 5(6 Suppl):S12-7. PubMed ID: 18456194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
    Galle J
    Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases.
    He F; Zuo L
    Int J Mol Sci; 2015 Nov; 16(11):27770-80. PubMed ID: 26610475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.